PLoS ONE (Jan 2015)

Multi-Parametric MRI and Texture Analysis to Visualize Spatial Histologic Heterogeneity and Tumor Extent in Glioblastoma.

  • Leland S Hu,
  • Shuluo Ning,
  • Jennifer M Eschbacher,
  • Nathan Gaw,
  • Amylou C Dueck,
  • Kris A Smith,
  • Peter Nakaji,
  • Jonathan Plasencia,
  • Sara Ranjbar,
  • Stephen J Price,
  • Nhan Tran,
  • Joseph Loftus,
  • Robert Jenkins,
  • Brian P O'Neill,
  • William Elmquist,
  • Leslie C Baxter,
  • Fei Gao,
  • David Frakes,
  • John P Karis,
  • Christine Zwart,
  • Kristin R Swanson,
  • Jann Sarkaria,
  • Teresa Wu,
  • J Ross Mitchell,
  • Jing Li

DOI
https://doi.org/10.1371/journal.pone.0141506
Journal volume & issue
Vol. 10, no. 11
p. e0141506

Abstract

Read online

Genetic profiling represents the future of neuro-oncology but suffers from inadequate biopsies in heterogeneous tumors like Glioblastoma (GBM). Contrast-enhanced MRI (CE-MRI) targets enhancing core (ENH) but yields adequate tumor in only ~60% of cases. Further, CE-MRI poorly localizes infiltrative tumor within surrounding non-enhancing parenchyma, or brain-around-tumor (BAT), despite the importance of characterizing this tumor segment, which universally recurs. In this study, we use multiple texture analysis and machine learning (ML) algorithms to analyze multi-parametric MRI, and produce new images indicating tumor-rich targets in GBM.We recruited primary GBM patients undergoing image-guided biopsies and acquired pre-operative MRI: CE-MRI, Dynamic-Susceptibility-weighted-Contrast-enhanced-MRI, and Diffusion Tensor Imaging. Following image coregistration and region of interest placement at biopsy locations, we compared MRI metrics and regional texture with histologic diagnoses of high- vs low-tumor content (≥80% vs <80% tumor nuclei) for corresponding samples. In a training set, we used three texture analysis algorithms and three ML methods to identify MRI-texture features that optimized model accuracy to distinguish tumor content. We confirmed model accuracy in a separate validation set.We collected 82 biopsies from 18 GBMs throughout ENH and BAT. The MRI-based model achieved 85% cross-validated accuracy to diagnose high- vs low-tumor in the training set (60 biopsies, 11 patients). The model achieved 81.8% accuracy in the validation set (22 biopsies, 7 patients).Multi-parametric MRI and texture analysis can help characterize and visualize GBM's spatial histologic heterogeneity to identify regional tumor-rich biopsy targets.